NEW YORK (Reuters Health) – Based on the results of a randomized, double-blind trial, more adolescents with acute migraine become pain-free within 2 hours after taking a combination…
NEW YORK (Reuters Health) – Blood pressure lowering provides protection against intracranial bleeding in patients with cerebrovascular disease, including those on antithrombotic therapy, according to results of a…
NEW YORK (Reuters Health) – Results of a new meta-analysis indicate that for patients with atrial fibrillation, treatment with one of the new oral anticoagulants rather than warfarin…
NEW YORK (Reuters Health) – Adding the investigational agent perampanel to concomitant antiepilepsy therapy reduces seizure frequency in patients with refractory partial-onset seizures, according to the results of…
NEW YORK (Reuters Health) – The clinical spectrum of intracranial hemorrhage was similar in patients treated with warfarin or dabigatran in the pivotal RE-LY trial, a new analysis…
Early neurologic outcomes are better with conventional carotid endarterectomy (CEA) than eversion CEA, but the eversion technique may be more effective for preventing stroke over the long term,…
NEW YORK (Reuters Health) – Administration of an erythropoiesis-stimulating agent or ESA (in this case, darbepoietin) to patients with severe traumatic brain injury (STBI) improves survival without increasing…
NEW YORK (Reuters Health) – A transdermal sumatriptan formulation, NP101, in development for acute treatment of migraine, remains effective during a year of successive uses, according to a…
NEW YORK (Reuters Health) – When antiepileptic drug therapy fails to control disabling temporal lobe epilepsy adequately, patients have a much better chance of becoming seizure free with…
NEW YORK (Reuters Health) – Patients receiving rehabilitation for prolonged disorders of consciousness after severe traumatic brain injury show an accelerated pace of cognitive recovery when treated with…